Lauren Averett Byers, MD, MS
机构: MD Anderson Cancer Center
每年引用次数
引用次数
引用: 40,634
H-指数: 75
I10-指数 : 171
出版物: 489
Delta-like ligand 3 immunohistochemical expression landscape in high-grade lung neuroendocrine tumors
Cibelle F Lima , Pedro S Rocha , Junya Fujimoto , Allison Stewart
Cancer Research 82 ( 12_Supplement) 5305 -5305
1
2022
YAP1 in relapsed pulmonary high-grade neuroendocrine carcinomas (NEC) is associated with CDKN2A loss, intact RB1, EMT and therapeutic vulnerability to MEK1 and CDK4/6 inhibition
C Allison Stewart , Lixia Diao , Yuanxin Xi , Runsheng Wang
Cancer Research 83 ( 7_Supplement) 4525 -4525
2023
A shared nearest neighbors approach for integrated, multi-platform networks and its application to the exploration of multiomics data from early-stage non-small cell lung cancers
Stephanie T Schmidt , Neal Akhave , Alexandre Reuben , Tina Cascone
MOLECULAR CANCER THERAPEUTICS 20 ( 12)
2021
Abstract P009: A shared nearest neighbors approach for integrated, multi-platform networks and its application to the exploration of multiomics data from early-stage non-small cell lung cancers
Stephanie T Schmidt , Neal Akhave , Alexandre Reuben , Tina Cascone
Molecular Cancer Therapeutics 20 ( 12_Supplement) P009 -P009
2021
Integrated multi-platform profiling of early-stage non-small cell lung cancer identifies relationship between disease recurrence and decreased native immune response in treatment-naïve resected NSCLC
Neal Akhave , Stephanie Schmidt , Alexandre Reuben , Tina Cascone
Cancer Research 81 ( 13_Supplement) 619 -619
2021
Abstract A153: Targeting DNA damage response upregulates PD-L1 level and promotes antitumor immunity in small-cell lung cancer
Triparna Sen , Bertha Leticia Rodriguez , Limo Chen , Naoto Morikawa
Cancer Immunology Research 7 ( 2_Supplement) A153 -A153
2019
Targeting MYC-enhanced glycolysis for the treatment of small cell lung cancer
Kasey R Cargill , C Allison Stewart , Elizabeth M Park , Kavya Ramkumar
Cancer & metabolism 9 1 -16
31
2021
DLL3 as an Emerging Target for the Treatment of Neuroendocrine Neoplasms
James Yao , Emily Bergsland , Rahul Aggarwal , Ana Aparicio
The oncologist 27 ( 11) 940 -951
30
2022
MiR-200c overexpression radiosensitizes lung cancer cells
Maria A Cortez , Vikas Bhardwaj , Yanai Zhan , George A Calin
Cancer Research 72 ( 8_Supplement) 1099 -1099
2012
Abstract P078: Cancer cell derived extracellular vesicles convey protein signatures of small cell lung carcinoma
Jody Vykoukal , Taketo Kato , Hiroyuki Katayama , Allison Stewart
Cancer Prevention Research 16 ( 1_Supplement) P078 -P078
2023
CDKN2A/p16 deletion in head and neck cancer cells is associated with CDK2 activation, replication stress, and vulnerability to CHK1 inhibition
Mayur A Gadhikar , Jiexin Zhang , Li Shen , Xiayu Rao
Cancer research 78 ( 3) 781 -797
43
2018
Clinical and molecular characterization of long-term survivors with extensive-stage small cell lung cancer treated with first-line atezolizumab plus carboplatin and etoposide
Stephen V Liu , Tony SK Mok , Barzin Y Nabet , Aaron S Mansfield
Lung Cancer 186 107418 -107418
7
2023
Inter-and intra-tumoral variations in ASCL1, NEUROD1, and POU2F3 transcriptional programs underlie three distinct molecular subtypes of small cell lung cancers
Carl M Gay , Lixia Diao , C Allison Stewart , Yuanxin Xi
Cancer Research 79 ( 13_Supplement) 3772 -3772
6
2019
The Aurora kinase A-inhibitor, alisertib, is a potential candidate for combination with immunotherapy in small cell lung cancer
Carminia M Della Corte , Liz Lauren Ajpacaja , Robert J Cardnell , Carl M Gay
MOLECULAR CANCER THERAPEUTICS 18 ( 12)
2
2019
Brief Report: Comprehensive Clinicogenomic Profiling of Small Cell Transformation From EGFR-Mutant NSCLC Informs Potential Therapeutic Targets
Bingnan Zhang , Whitney Lewis , C Allison Stewart , Benjamin B Morris
JTO Clinical and Research Reports 5 ( 2) 100623 -100623
1
2024
Unfolding the secrets of small cell lung cancer progression: Novel approaches and insights through rapid autopsies
Zsolt Megyesfalvi , Simon Heeke , Benjamin J Drapkin , Anna Solta
Cancer cell 41 ( 9) 1535 -1540
1
2023
DNA damage repair targeting upregulates PD-L1 level and potentiates the effect of PD-L1 blockade in small cell lung cancer
Triparna Sen , Limo Chen , B Leticia Rodriguez , Carl M Gay
MOLECULAR CANCER THERAPEUTICS 17 ( 1)
1
2018
Differential sensitivity analysis for resistant malignancies (DISARM), a novel approach for drug screen analysis, identifies common candidate drugs across platinum-resistant cancer types
Carl M Gay , Pan Tong , Robert J Cardnell , Xiao Su
Cancer Research 77 ( 13_Supplement) 1560 -1560
1
2017
LKB1 overexpression regulates DNA repair pathway and sensitivity to radiation in LKB1 mutant non-small cell lung cancer cell lines.
Chao Yang , Uma Giri , Maria Angelica Cortez , Jayanthi Gudikote
Cancer Research 73 ( 8_Supplement) 1589 -1589
1
2013
Methods and systems for diagnosis, classification, and treatment of small cell lung cancer and other high-grade neuroendocrine carcinomas
John V Heymach , Simon Heeke , Lauren A Byers
2024